Toll-like receptors (TLRs) are critical components of innate immunity, recognizing bacterial microorganisms and initiating local inflammatory responses. In this study, we assessed the impact of genetic variation in TLR genes on cervical concentrations of pro-and anti-inflammatory cytokines, and determined whether this relationship is influenced by bacterial vaginosis (BV). A total of 4 single nucleotide polymorphisms (SNPs) in TLR2 and 12 in TLR4 were examined for associations with 10 cervical pro-and anti-inflammatory cytokine concentrations in 91 African-American (AA) and 97 European-American (EA) women in the first trimester of pregnancy. In EAs, individuals with the TT genotype at rs1554973 (TLR4) had higher cervical concentrations of interleukin-1 beta (IL-1b) compared with those with the CT or TT genotypes (P ¼ 1.5 Â 10 À5 ), which remains significant after correction for multiple testing. This association was more significant in women with BV (P ¼ 5 Â 10 À3 ) than those without BV (P ¼ 0.02). This SNP was also associated with cervical concentrations of IL-1a, IL-6, IL-8 and IP10 (interferon-gamma-inducible protein 10) (P ¼ 6 Â 10 À3 , 0.03, 0.05, 6 Â 10 À3 , respectively). Our study demonstrates that TLR4 is an important mediator of pro-inflammatory cervical immune responses, particularly in EA women and especially in those with microbial disorders such as BV.
Introduction
Local innate immunity is critical in regulating the response to bacteria in the genital tract. 1, 2 Several studies have demonstrated that elevated amniotic fluid levels of pro-inflammatory cytokines leads to a hyper-responsive immunity that is associated with adverse birth outcomes such as preterm birth (PTB). [3] [4] [5] Conversely, low concentrations of multiple cytokines create a hypo-responsiveness that can predispose women to infection and inflammation, such as chorioamnionitis. 6 Genetic control of immunity, particularly in autoimmune diseases such as lupus and rheumatoid arthritis, is well characterized; however, few studies have focused on cervical immunity. [7] [8] [9] Genetic polymorphisms in genes involved in the local innate immune response may lead to either a hyporesponsive immunity that would increase the susceptibility of developing infections or a hyper-responsive immunity that could predispose women to adverse reproductive outcomes.
Toll-like receptors (TLRs) are important components of the innate immune system, and are essential in recognizing bacterial microorganisms and initiating the appropriate immune response. 10, 11 TLRs, in particular, TLR2 and TLR4, are expressed in the female reproductive tract and in decidual cells at the maternal-fetal interface. 12, 13 Therefore, these genes may be important in the regulation of cervical immunity.
In addition, it is likely that TLRs are involved in the pathogenesis and response to vaginal microbial disorders such as bacterial vaginosis (BV). BV is a polymicrobial vaginal disorder that can cause serious adverse reproductive outcomes, especially in pregnant women, and is associated with adverse pregnancy outcomes such as miscarriage and PTB. [14] [15] [16] BV is characterized by a mixture of Gram-positive and Gram-negative bacteria; TLR2 recognizes Gram-positive bacteria, whereas TLR4 recognizes lipopolysaccharide, a component of Gramnegative bacteria. Therefore, these genes are plausible candidates to study in relation to BV. Genetic polymorphisms in TLR genes may affect downstream factors, such as pro-and anti-inflammatory cytokine concentrations, depending on the presence of BV. This may lead to either an increased risk for BV and/or adverse pregnancy outcomes, such as PTB, in women with BV.
BV is more common in African Americans (AA), and AA women are more likely to experience adverse pregnancy outcomes, such as PTB, than their European-American (EA) counterparts. [17] [18] [19] It is well established that AA and EA women have different immune responses to reproductive tract infection as well as differing genetic backgrounds, particularly in immunity genes such as the interleukins (ILs), other cytokines and TLR genes. 3, [20] [21] [22] [23] [24] However, few studies have examined how ethnic differences in the genetic variation of TLR genes affect cytokine responses. It is possible that different distributions of variants in these genes contribute to the ethnic disparity observed in the immune response to microorganisms in the genital tract.
To determine whether single nucleotide polymorphisms (SNPs) in TLR2 or TLR4 are associated with cervical cytokine concentrations, three anti-inflammatory cytokines (IL-4, IL-10, and IL-13) and seven pro-inflammatory cytokines (IL-1a, IL-1b, IL-6, IL-8, IP10 (interferongamma-inducible protein 10), MCP1(monocyte chemotactic protein 1) and tumor necrosis factor alpha (TNF)-a) were examined in AA and EA women. These cytokines have previously been shown to associate with BV, PTB and/or genetic variation that differentiate immune responses in AA and EA women. 3, 9, 20, [25] [26] [27] Associations were also examined for the interaction between these polymorphisms and BV status.
Materials and methods
We performed a prospective, observational cohort study of women from the general obstetrical population seeking prenatal care at the Magee-Womens Hospital prenatal clinic between April 2005 and June 2006. This study was approved by the Institutional Review Boards of the University of Pittsburgh and Vanderbilt University. Inclusion criteria for the cohort study were singleton intrauterine gestation before 13 weeks. Exclusion criteria included vaginal bleeding, fetal anomalies, known thrombophilias, pre-gestational diabetes mellitus, chronic hypertension requiring medication, current or planned cervical cerclage, immune compromise (HIV positive, use of systemic steroids within 6 months and use of post-transplant immunosuppressive medication) and autoimmune disease (inflammatory bowel disease, systemic lupus erythematosus, rheumatoid arthritis and scleroderma). These exclusion criteria were determined before study enrollment because they are believed to be associated with PTB or an alteration in the immune status of the women, which would confound the associations we proposed to examine. After giving informed consent, all women provided demographic, medical and clinical information through standardized, closed-question, research interviews administered by research personnel.
Cervical swabs from women were obtained for the diagnosis of Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis, and vaginal swabs were obtained for the diagnosis of BV. BV was diagnosed by vaginal pH44.7 and a score of 7 through 10 from a Gram-stained vaginal smear, interpreted using the Nugent method. 28 The following cytokines were evaluated: IL-1a, IL-1b, IL-4, IL-6, IL-8, IL-10, IL-13, IP10, MCP1 and TNF-a. Cytokine concentrations were measured in nanograms per milliliter, using the Luminex LabMAP multiplex system and a BeadLyte bead kit (Upstate, Lake Placid, NY, USA). Each assay run gave an intra-and inter-assay variation of o10%. Details on collection and quantification of vaginal cytokine concentrations are described elsewhere. 9, 29 Women were excluded from data analysis if they were positive for N. gonorrhoeae, C. trachomatis or T. vaginalis, were not self identified as EA or AA, had an intermediate BV score, had no Gram-stain score, were under 18 years or had no cytokine measurements. Thus, there were 93 AAs and 98 EAs analyzed in this study.
Four tagSNPs in TLR2 and twelve tagSNPs in TLR4 were examined for association with cervical cytokine concentrations. TagSNPs were selected based on their ability to tag surrounding variants in the Caucasian (CEPH) and Yoruba (YRI) populations of the HapMap database (http://www.hapmap.org). A minor allele frequency of 0.07 in CEPH and 0.20 in YRI, and an r 2 of 0.80 were used to determine tagSNPs. Genotyping was performed on the Illumina GoldenGate platform (Illumina, San Diego, CA, USA). There was an average SNP genotyping efficiency of 99.8%, and all individuals selected for analysis had a genotyping efficiency of greater than 95%. Allelic and genotypic distributions were compared between ethnic groups, using Fisher exact tests. Hardy-Weinberg equilibrium was calculated for each marker using Fisher exact tests. The above were performed in Powermarker. 30 Linkage disequilibrium was calculated using the software Haploview. 31 To assess the accuracy of self-reported ancestry, structure analysis was performed on 1337 markers that cover 22 chromosomes with Structure 2.2. 32 This analysis indicated two distinct clusters in almost complete agreement with the self-reported ancestry, with the exception of one selfreported EA who clustered with self-reported AA and two self-reported AA who clustered with self-reported EA. Therefore, these individuals were removed from subsequent analysis, leaving 97 EAs and 91 AAs for analysis.
The relationship between each cytokine and polymorphisms in TLR2 and TLR4 was analyzed using twoway ANOVA (analysis of variance) or Kruskal-Wallis non-parametric tests, depending on the normality of the distribution for any given cytokine. None of the cytokines examined were normally distributed. After transforming with either natural log or box cox, the box cox transformation provided the best fit (Shapiro-Wilk P40.01 in both EA and AA) for IL-1a, IL-1b, IL-6, IP10 and MCP1. ANOVA analyses were performed for these cytokines stratified by race and included the interaction between BV status and SNP. The full model was:
Bartlett's test for equal variances was performed for all interaction terms and reported for SNPs associated with cytokine concentration, if significant. Additive, dominant and recessive models were analyzed for all cytokine concentrations; however, models were excluded if there were fewer than five individuals for any genotype in the model.
For those cytokines not normally distributed after transformation (IL-13, IL-8 and TNF-a), Kruskal-Wallis tests were performed to determine whether cytokine concentration differed by genotype and BV status. In addition, Kruskal-Wallis tests were performed for IL-4 and IL-10 as there were zero measurement values. Therefore, for additive models, there were six strata (BV þ with three genotypic classes and BV À with three genotypic classes), and for dominant and recessive models, there were four strata (BV þ with two genotypic classes and BV À with two genotypic classes). Again to limit the number of tests performed, genetic models were only examined if there were five or more individuals per genotypic class.
The best model (the model with the most significant Pvalue (either SNP or interaction)) was considered for subsequent analysis. Significant SNP or interaction effects were analyzed further with the Sidak test to determine which group (BV þ or BV À ) was driving the significance. The Sidak test calculates P-values that are corrected for multiple testing. Calculations were performed using Stata version 10 (StataCorp, College Station, TX, USA). A total of 955 tests were performed and results were adjusted for this number of tests with FDR (false discovery rate) (q ¼ 0.2). 33 This number included tests for all evaluated genetic models, cytokine concentrations, both races and interaction, and single SNP main effects.
Results
All of the SNPs in TLR2 and TLR4 had significant differences in either allele or genotype frequencies between ethnic groups; of these, all 4 SNPs in TLR2 and 10 of the 12 SNPs in TLR4 had significant allelic or genotypic P-values less than 0.001 (Supplementary Table 1 ). There were two SNPs (rs1898830 and rs7856729) in EA and none in AA that deviated from Hardy-Weinberg equilibrium; however, none of these had P-values less than 0.01.
In EAs, three SNPs in TLR2 associated with IL-1a, IL-10 or IP10 concentrations. In addition, eight SNPs in TLR4 associated with multiple cytokines, including IL-1a, IL-1b, IL-6, IL-8, IL-10, IP10 and MCP1, for a total of 24 associations (Supplementary Table 2a ). After correction for multiple testing, two SNPs in TLR4 (rs1554973 and rs7856729) remained significantly associated with IL-1b concentrations (P ¼ 1.5 Â 10 À5 and 5 Â 10 À4 , respectively) in EAs (Table 1 and Supplementary Table 2a ). The most significant association was in women with the TT genotype at rs1554973, who had higher concentrations of IL-1b than that in women with the CC or CT genotype (mean transformed concentrations 5.17 vs 3.82) (Figure 1a, Supplementary Table 3 ). This effect was more significant in BV þ than in BV À women (P ¼ 5 Â 10 À3 vs 0.02, respectively). In addition, although not significant after correction for multiple testing with FDR, the TT genotype at rs1554973 was associated with higher IL-1a, IL-6, IL-8 concentrations, whereas the CC genotype was associated with higher IP10 concentrations (Table 1) . Pair-wise comparisons between BV status and genotype did not reveal any significant associations after correction for multiple testing for rs1554973, and IL-6 or IP10 concentrations; however, there were higher concentrations of both IL-1a and IL-8 in BV À women (P ¼ 0.03 and 0.01, respectively) (Figures 1b and c, Table 1 and Supplementary Table 3) . These associations were not significant in BV þ women. In AAs, there was one association involving a SNP in TLR2 with IL-1a concentrations and eleven associations involving eight SNPs in TLR4 with various cytokines, including IL-1a, IL-4, IL-6, IL-8, IP10, MCP1 and TNF-a.
None of these associations remained significant after correcting for multiple testing (Supplementary Table 2b ).
Discussion
It remains unclear as to why some women with BV experience adverse pregnancy outcomes such as PTB, whereas others do not, or why some women are more susceptible to vaginal microbial disorders such as BV. Several studies have observed higher serum, amniotic fluid or vaginal concentrations of IL-1b, IL-6, IL-8 and TNF-a in women with BV or in those experiencing PTB. 5, 27, 29, [34] [35] [36] Other studies have found that low levels of multiple cytokines, particularly pro-inflammatory cytokines, are associated with infection and inflammation such as chorioamnionitis. 6 TLRs, particularly TLR2 and TLR4, are important components of the innate immune system that stimulate the production of pro-and anti- inflammatory cytokines. However, only one study, to our knowledge, has assessed the impact of genetic variation in TLR genes on cervical cytokine production. 37 In the present study, we examine genetic polymorphisms in TLR2 and TLR4 for association with cervical pro-and anti-inflammatory cytokines, and determine whether BV status interacts with these polymorphisms to affect cervical cytokine concentrations.
We identified two TLR4 SNPs (rs1554973 and rs7856729) located in the 3 0 -UTR that significantly associated with cervical IL-1b concentrations as well as with other pro-inflammatory cytokines in EA, but not AA women. These SNPs are in strong linkage disequilibrium with one another in our EA sample (D 0 ¼ 1.0, r 2 ¼ 0.68), indicating that the association may be because of a single variant that is tagged by them. Previously, a variant in TLR4 (rs4986790) was found to be associated with an increase in vaginal pH, G. vaginalis, anaerobic Gram-negative rods, Prevotella, Bacteroides and Porphyromonas. 37 In addition, women with the AA genotype at rs4986790, and colonization of G. vaginalis and/or Gramnegative rods had significantly higher vaginal IL-1b concentrations than in women without BV, an effect not present in women with the AG or GG genotypes. 37 This SNP, rs4986790, has also been associated with PTB. 38, 39 SNP, rs4986790, is a missense mutation (D299G), and the AG and GG genotypes have been shown to cause decreased responsiveness to inhaled lipopolysaccharide in humans. 40 The impairment of lipopolysaccharide responsiveness due to this mutation may be a mechanistic explanation for the association of lower proinflammatory cytokines in women with the AG or GG genotypes. Although rs4986790 was not genotyped in our data, in the Caucasian samples from the HapMap data, it is in strong linkage disequilibrium with rs1554973 (D 0 ¼ 1.0), a SNP that significantly associates with IL-1b concentrations in our study, particularly in women with BV. Therefore, it is possible that our results mark an association of the missense mutation (rs4986790) with cervical IL-1b concentrations in the presence of BV. Our findings support the hypothesis that TLR genes, specifically TLR4, function in response primarily to Gramnegative bacteria in the cervical milieu. One example of such a Gram-negative bacteria that may act as an important agent in the cervical milieu is Prevotella.
41
Toll-like receptor genes are shown to be critical in regulation of the immune response. 42 We have demonstrated that TLR4 is associated with cervical proinflammatory concentrations, and this association differs not only by BV status but also by geographic ancestry. We have identified factors that may not only predispose women to an increased risk of BV but may also increase the risk of adverse pregnancy outcomes, such as PTB, in women with BV. In addition, we have identified associations in the TLR genes that give greater insight into the biological processes involved in cytokine regulation, the mechanism of BV and possibly disparity in clinical phenotypes such as PTB. These data may indicate that the increased risk of adverse pregnancy outcomes in the presence of BV are not due to BV per se, but to the genetic factors that increase risk of both outcomes due to effects on the immune response that impacts both phenotypes. 
